VENADO represents an entirely new product family in K2M's growing biologics portfolio, already featuring VIKOS® Allograft Systems and VESUVIUSTM Osteobiologic Systems.
K2M, Inc. announced a partnership with Cadwell Laboratories, Inc. to provide a neuromonitoring solution for the company's RAVINE® Lateral Access System.
Recent additions of BLUE RIDGE™ Hybrid and PYRENEES® Translational to K2M's product offerings enable the company to address all segments of the cervical fixation market.
K2M, Inc. today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the SANTORINI™ Corpectomy Cage Systems.